4 mL injection of AMPION™

BIOLOGICAL2 trials

Sponsors

Ampio Pharmaceuticals. Inc.

Conditions

Osteoarthritis of the KneeSevere Osteoarthritis of the Knee

Phase 3

A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee

CompletedNCT02556710

Ampio Pharmaceuticals. Inc.Osteoarthritis of the Knee

Start: 2015-09-30End: 2016-06-30Updated: 2022-08-09

Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

TerminatedNCT03349645

Ampio Pharmaceuticals. Inc.Severe Osteoarthritis of the Knee

Start: 2017-12-08End: 2018-10-04Updated: 2022-10-03

Related Papers

Intra-articular injection of the anti-inflammatory compound LMWF-5A in adults with severe osteoarthritis: a double-blind prospective randomized controlled multi-center safety and efficacy trial.

2018-06-1810 citations